After confirming the specificity of the anti-CHTM1 antibody, we analyzed 36 lung cancer patient samples by immunohistochemical staining; our results indicated that 18/36 (50%) tumor specimens exhibited increased CHTM1 level. This evidence concerns the gene CHCHD5 and neoplasm.